Mark G. Mortenson
Net Worth

Last updated:

What is Mark G. Mortenson net worth?

The estimated net worth of Mr. Mark G. Mortenson is at least $1,597,665 as of 30 Sep 2024. He owns shares worth $127,665 as insider, has earned $50,010 from insider trading and has received compensation worth at least $1,419,990 in Clene Inc..

What is the salary of Mark G. Mortenson?

Mr. Mark G. Mortenson salary is $473,330 per year as Co-Founder & Chief Science Officer in Clene Inc..

How old is Mark G. Mortenson?

Mr. Mark G. Mortenson is 67 years old, born in 1958.

What stocks does Mark G. Mortenson currently own?

As insider, Mr. Mark G. Mortenson owns shares in one company:

Company Title Shares Price per share Total value
Clene Inc. (CLNN) Co-Founder & Chief Science Officer 28,949 $4.41 $127,665

What does Clene Inc. do?

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Mark G. Mortenson insider trading

Clene Inc.

Mr. Mark G. Mortenson has made only one insider trade between 2022-2024, according to the Form 4 filled with the SEC. He purchased 20,512 units of CLNN stock worth $97,432 on 30 Sep 2024.

As of 30 Sep 2024 he still owns at least 28,949 units of CLNN stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 20,512 $4.75 $97,432
Sale
Common Stock 20,247 $2.47 $50,010

Clene key executives

Clene Inc. executives and other stock owners filed with the SEC: